HAS-BLED Score Calculator

About This HAS-BLED Score Calculator

This HAS-BLED Score Calculator is a clinical risk stratification tool for estimating the one-year risk of major bleeding in patients with atrial fibrillation (AFib) who are candidates for oral anticoagulation. It serves as a simple, memorable mnemonic to help clinicians identify modifiable risk factors, facilitate a discussion about risks and benefits with the patient, and guide the intensity of follow-up. The output from this HAS-BLED Score Calculator supports, not replaces, clinical judgment.

Scoring System Explained

The HAS-BLED score is the sum of points from the following clinical characteristics:

Mnemonic	Condition	Points
H	Hypertension (uncontrolled SBP >160 mmHg)	+1
A	Abnormal renal function (dialysis, transplant, Cr ≥2.26 mg/dL)	+1
A	Abnormal liver function (cirrhosis, bili >2x ULN, etc.)	+1
S	Stroke (prior history)	+1
B	Bleeding history or predisposition	+1
L	Labile INRs (TTR <60% on warfarin)	+1
E	Elderly (age > 65 years)	+1
D	Drugs (concomitant antiplatelets/NSAIDs) or Alcohol abuse	+1

Clinical Interpretation & Limitations

The total score correlates with an estimated number of major bleeds per 100 patient-years.

HAS-BLED Score	Bleeds per 100 patient-years	Risk Category
0	1.13	Low/Moderate Risk
1	1.02
2	1.88
3	3.74	High Risk
4	8.70
≥5	12.5

Limitations

While extremely useful, the HAS-BLED score has limitations. It was primarily validated in patients taking warfarin; while it still has predictive value for patients on DOACs, the absolute risks are lower. It does not include all possible bleeding risk factors and should be used as one component of a comprehensive clinical assessment. Current ACC/AHA (2023) and ESC (2024) atrial fibrillation guidelines emphasize that bleeding-risk scores must not be used in isolation to withhold or stop anticoagulation; the primary purpose is to identify and treat modifiable bleeding risk factors and to flag patients for earlier, more frequent review.

Frequently Asked Questions (FAQ)

1. What does a high HAS-BLED score mean for my treatment?

It does not mean you should withhold anticoagulation. The risk of stroke in many patients with AFib is often much higher than the risk of bleeding. A high score (≥3) prompts a clinical review to identify and address modifiable risk factors (e.g., better blood pressure control, reviewing medications like NSAIDs) and necessitates more frequent monitoring.

2. How is the “Abnormal Renal/Liver Function” component scored?

This component can contribute up to 2 points: one for significant renal disease and one for significant liver disease. This calculator simplifies the input to None (0 pts), One (1 pt), or Both (2 pts).

3. How does this score relate to the CHA₂DS₂-VASc score?

They are complementary. The CHA₂DS₂-VASc score estimates the risk of ischemic stroke to determine *if* a patient needs anticoagulation. The HAS-BLED score estimates the risk of bleeding to determine *how cautiously* to proceed and how closely to monitor the patient once anticoagulation is started.

4. What is a “major bleed”?

A major bleed is typically defined as any bleeding that is intracranial, requires hospitalization, results in a significant drop in hemoglobin (>2 g/dL), and/or requires a blood transfusion.